Insider Transaction Report for Arcutis Biotherapeutics, Inc.

This filing details insider transactions for Arcutis Biotherapeutics, Inc. (ARQT) on June 5, 2026. Sue-Jean Lin, a director, acquired 5,778 shares of Common Stock and was granted 16,667 stock options. The stock acquisition and option grant are part of her compensation as a non-employee director. The RSUs granted will vest on the earlier of the first anniversary of the grant date or immediately before the next annual meeting, subject to continued service. The settlement of these RSUs has been deferred by the Reporting Person. The stock options vest and become exercisable under similar conditions. Both transactions are marked with a direct ownership nature.